ID   Akata-EBV-N
AC   CVCL_VN89
SY   Akata-
DR   cancercelllines; CVCL_VN89
DR   JCRB; JCRB1765
DR   Wikidata; Q93324016
RX   PubMed=8057484;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1765
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0148 ! Akata
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 11
//
RX   PubMed=8057484; DOI=10.1128/JVI.68.9.6069-6073.1994; PMCID=PMC237015;
RA   Shimizu N., Tanabe-Tochikura A., Kuroiwa Y., Takada K.;
RT   "Isolation of Epstein-Barr virus (EBV)-negative cell clones from the
RT   EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes
RT   of BL cells are dependent on EBV.";
RL   J. Virol. 68:6069-6073(1994).
//